KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Interest Expenses (2016 - 2026)

Cme has reported Interest Expenses over the past 18 years, most recently at $43.6 million for Q1 2026.

  • Quarterly Interest Expenses rose 4.56% to $43.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $175.3 million through Mar 2026, up 7.74% year-over-year, with the annual reading at $173.4 million for FY2025, 7.77% up from the prior year.
  • Interest Expenses was $43.6 million for Q1 2026 at Cme, roughly flat from $43.7 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $44.0 million in Q2 2025 and troughed at $39.6 million in Q3 2023.
  • The 5-year median for Interest Expenses is $40.2 million (2023), against an average of $41.2 million.
  • Biggest five-year swings in Interest Expenses: decreased 6.12% in 2023 and later rose 9.73% in 2025.
  • Tracing CME's Interest Expenses over 5 years: stood at $39.9 million in 2022, then fell by 0.5% to $39.7 million in 2023, then grew by 2.52% to $40.7 million in 2024, then grew by 7.37% to $43.7 million in 2025, then fell by 0.23% to $43.6 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $43.6 million, $43.7 million, and $44.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.